SIX Financial Information

Enter Ticker Symbol:

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bayer Aktiengesellschaft (BAYRY : OTC)

• Company Description

Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
Number of Employees: 92,815

• Price / Volume Information

Yesterday's Closing Price: $8.23 Daily Weekly Monthly

20 Day Moving Average: 393,954 shares

Shares Outstanding: 3,929.70 (millions)

Market Capitalization: $32,341.40 (millions)

Beta: 0.93

52 Week High: $8.65

52 Week Low: $4.79

Short Interest Ratio:

% Price Change % Price Change Relative to S&P 500

4 Week 6.61% 4.73%

12 Week 5.92% -3.79%

Year To Date 68.65% 54.60%

• Address & Contact Information

Street Address Phone / Fax Email Address Web URL

Kaiser-Wilhelm-Allee 1
-
Leverkusen,2M 51368
DEU ph: 49-21-4-30-1
fax: 49-21-4306-6328 peter.dahlhoff@bayer.com http://www.bayer.com

• General Corporate Information

Officers

Werner Baumann - Chief executive officer and Chairman
Wolfgang Nickl - Finance
Hartmut Klusik - Human Resources; Technology
Kemal Malik - Innovation
Erica Mann - Management members

Peer Information

Bayer Aktiengesellschaft (AGN.)
Bayer Aktiengesellschaft (NVS)
Bayer Aktiengesellschaft (NVO)
Bayer Aktiengesellschaft (LLY)
Bayer Aktiengesellschaft (RHHBY)
Bayer Aktiengesellschaft (JNJ)

Industry / Sector / Ticker Info

Analyst Coverage: No
Industry Group: Large Cap Pharma
Sector: Medical
CUSIP: 072730302
SIC: 2834

Fiscal Year

Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/11/25

Share - Related Items

Shares Outstanding: 3,929.70
Most Recent Split Date: 9.00 (4.00:1)
Beta: 0.93
Market Capitalization: $32,341.40 (millions)

• EPS Information    • Dividend Information

Analyst Coverage: No Dividend Yield: 0.28%

Current Fiscal Quarter EPS Consensus Estimate: $0.13 Indicated Annual Dividend: $0.02

Current Fiscal Year EPS Consensus Estimate: $1.37 Payout Ratio: 0.02

Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: -0.16

Estmated Long-Term EPS Growth Rate: 1.60% Last Dividend Paid: NA - $0.00

Next EPS Report Date: 11/11/25

• Fundamental Ratios

P/E

Current FY Estimate: 6.01
Trailing 12 Months: 6.10
PEG Ratio: 3.75

Price Ratios

Price/Book: 0.93
Price/Cash Flow: 2.17
Price / Sales: 0.65

EPS Growth

vs. Year Ago Period: 40.00%
vs. Previous Quarter: -46.15%

Sales Growth

vs. Year Ago Period: 1.58%
vs. Previous Quarter: -15.69%

ROE

06/30/25 - 15.44
03/31/25 - 13.94
12/31/24 - 14.69

ROA

06/30/25 - 4.49
03/31/25 - 4.09
12/31/24 - 4.31

Current Ratio

06/30/25 - 1.13
03/31/25 - 1.25
12/31/24 - 1.19

Quick Ratio

06/30/25 - 0.73
03/31/25 - 0.79
12/31/24 - 0.72

Operating Margin

06/30/25 - 10.58
03/31/25 - 9.87
12/31/24 - 10.63

Net Margin

06/30/25 - -7.61
03/31/25 - -7.26
12/31/24 - -5.59

Pre-Tax Margin

06/30/25 - -4.39
03/31/25 - -6.83
12/31/24 - -5.01

Book Value

06/30/25 - 8.81
03/31/25 - 8.73
12/31/24 - 8.82

Inventory Turnover

06/30/25 - 1.64
03/31/25 - 1.64
12/31/24 - 1.60

Debt-to-Equity

06/30/25 - 1.04
03/31/25 - 1.07
12/31/24 - 1.11

Debt-to-Capital

06/30/25 - 50.97
03/31/25 - 51.80
12/31/24 - 52.56

Powered by Zacks Investment Research ©